Skip to main content
. 2023 Oct 26;15(10):487–499. doi: 10.4330/wjc.v15.i10.487

Table 1.

Cardiac magnetic resonance findings in hypertrophic cardiomyopathy and phenocopies


Morphologic features
Tissue characterization
LGE
Mapping
ECV
Athlete’s heart Balanced increase in wall thickness and cavity size Absent or in RV insertion points Normal or decreased T1 Normal or decreased
Hypertrophic cardiomyopathy (sarcomeric) Typically asymmetric LVH, with septal predominance Mid-mural, patchy, affecting most hypertrophied segments; transmural in advanced stages Increased native T1, regardless of LGE presence, reflecting interstitial fibrosis Increased ECV attributed to fibrosis
Amyloidosis Symmetric or asymmetric LVH Subendocardial, global, diffuse; transmural in advanced stages. LGE reflects infiltration, not fibrosis; abnormal gadolinium kinetics Marked increase in native T1 value (AL > ATTR) due to protein accumulation Markedly increased ECV reflecting protein accumulation
Fabry disease Concentric LVH, prominent papillary muscles, RV hypertrophy Mid-mural, basal inferolateral segment Decreased native T1 values (lipid storage); pseudonormalization in advance stages due to fibrosis. Elevated T2 levels due to inflammation Normal ECV

ECV: Extracellular volume; LGE: Late gadolinium enhancement; LVH: Left ventricular hypertrophy; RV: Right ventricle.